GRMN vs STRO
Garmin Ltd (GRMN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported GRMN revenue for 2024-12-28 was $6.30B. Net income was $1.41B. Revenue was up 20.4% from 2023-12-30 to 2024-12-28. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
GRMN currently screens at market cap $41.35B and trailing P/E 28.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the GRMN and STRO stock pages for the full models.
Not investment advice.